Three House committee chairmen told ActBlue CEO Regina Wallace-Jones on Tuesday that they are prepared to hold her in contempt of Congress, accusing the Democratic fundraising giant of deliberately withholding subpoenaed documents and misleading investigators probing whether the platform enabled fraudulent and foreign political donations.
The letter, signed by House Administration Committee Chairman Bryan Steil of Wisconsin, Judiciary Committee Chairman Jim Jordan of Ohio, and Oversight Committee Chairman James Comer of Kentucky, marks a sharp escalation in an investigation that has dragged on for more than a year with what Republicans say has been inadequate cooperation from ActBlue.
CBS News reported that a House Republican aide confirmed all options are on the table to compel document production, including a vote to hold Wallace-Jones in contempt. Under federal law, willful failure to comply with a congressional subpoena is a misdemeanor enforced by the Department of Justice.
The committees gave Wallace-Jones two weeks to comply with outstanding subpoenas and a fresh round of document requests. The new demands focus specifically on ActBlue's policies, or lack thereof, to prevent political donations by foreign nationals, and on any evidence of the "potential or actual use of ActBlue by foreign nationals to make political contributions."
The timeline tells a clear story of diminishing cooperation. House Republicans first subpoenaed ActBlue last July for documents and communications. That subpoena came after a New York Times report detailed an exodus of staff from the company, a detail that, in hindsight, looks less like normal turnover and more like people heading for the exits.
As Fox News previously reported, ActBlue initially provided documents voluntarily but later suspended cooperation entirely, forcing the committees to resort to compulsory process. The committees noted in their earlier communications that ActBlue's refusal to cooperate prompted the escalation to subpoenas with hard deadlines.
Now, nearly a year after those subpoenas were issued, the three chairmen say the company has not only failed to produce responsive materials but may have actively concealed them.
The Tuesday letter was blunt. The chairmen wrote that there is "considerable reason to believe that ActBlue may have deliberately withheld" documents "to impede our investigation." They added that the committees "are prepared to use available mechanisms to enforce our subpoenas."
That language is not boilerplate. It is the procedural precursor to a contempt referral, and it signals that House Republicans believe they have enough evidence of obstruction to move forward if ActBlue does not change course.
The contempt threat gained additional force from a New York Times report published roughly a week before the Tuesday letter. That report revealed that a law firm working for ActBlue had found that Wallace-Jones may have misled Congress about the platform's vetting procedures for donors.
The internal legal warnings that ActBlue's own lawyers raised are particularly damaging. A February 2025 internal memo from Covington & Burling, the law firm retained by ActBlue, warned that it could be alleged the platform accepted or facilitated foreign-national contributions into American elections. That is not a Republican talking point. That is ActBlue's own legal counsel raising the alarm.
The New York Post reported that the chairmen's letter specifically cited the Times report, writing that "recent reporting by the New York Times confirms our initial findings and strongly suggests that ActBlue deliberately obstructed the Committees' investigation, including through misleading statements and noncompliance with our subpoenas."
The chairmen further stated that ActBlue's conduct "has impeded the Committees' ability to develop legislation protecting our elections against fraudulent political contributions and foreign interference." That framing matters. It moves the conversation beyond partisan gamesmanship and into the territory of legislative obstruction, a company allegedly preventing Congress from doing its constitutional job of writing election-integrity law.
ActBlue has pushed back on every front. A spokesperson called the contempt threat "a desperate attempt to deflect from the Right's ongoing issues," adding that "no platform does more to protect the integrity of small-dollar democracy than ActBlue."
The spokesperson also insisted that "we have always been forthcoming with Congress, and we will not be intimidated by partisan theater."
In an earlier statement from early April, ActBlue said Wallace-Jones "never made false statements to Congress" and that the company "remains stable and stronger than ever."
Those denials now sit awkwardly beside the findings of ActBlue's own retained law firm. When your own lawyers warn that your conduct could be characterized as facilitating illegal foreign donations, and you then tell Congress everything is fine, the gap between those two positions is not "partisan theater." It is a credibility problem.
The broader investigation into whether ActBlue misled Congress on foreign donations has been building for months, and the evidence trail keeps getting worse for the platform, not better.
The congressional probe is not happening in isolation. Last April, President Trump signed an executive order directing the Department of Justice to investigate what the order described as "extremely troubling evidence that online fundraising platforms have been willing participants in schemes to launder excessive and prohibited contributions to political candidates and committees."
The executive order specifically targeted "unlawful 'straw donor' and foreign contributions in American elections." While the order did not name ActBlue, the platform is the dominant online fundraising tool for Democratic campaigns and committees, making it the obvious subject of any such investigation.
ActBlue processes grassroots contributions for Democratic campaigns across the country. Its Republican counterpart, WinRed, serves a similar function for GOP candidates. The distinction Republicans have drawn is not about the existence of online fundraising platforms but about what they describe as ActBlue's "unserious approach to fraud prevention", a charge that gains weight when the company's own legal advisors raised similar concerns internally.
The pattern of Democratic fundraising operations facing scrutiny over donor sources is not new, but the ActBlue case stands out for the sheer volume of money flowing through the platform and the seriousness of the foreign-donation allegations.
Wallace-Jones and ActBlue now face a two-week deadline to comply with the outstanding subpoenas and the new document requests. If they refuse, or produce what the committees consider an inadequate response, the path to a contempt vote is clear.
A contempt referral would go to the full House for a vote. If approved, the matter would be referred to the Department of Justice for prosecution. Given that President Trump has already directed DOJ to investigate online fundraising platforms, a contempt referral from Congress would land on receptive ground.
Several open questions remain. What specific documents do Republicans believe ActBlue withheld? How does ActBlue reconcile its public denials with the internal Covington & Burling memo? And will the platform comply before the deadline, or force a confrontation it may not win?
This is not, as ActBlue claims, a case of congressional Republicans manufacturing a controversy. Three committees spent more than a year investigating. They issued subpoenas. They obtained cooperation, then watched it evaporate. A major law firm retained by ActBlue itself flagged potential legal exposure. And the New York Times, not exactly a right-wing outlet, published reporting that corroborated the committees' suspicions.
The broader landscape of Democrats facing serious congressional and legal scrutiny continues to grow, and ActBlue's troubles may be the most consequential case of the lot, given the platform's central role in financing the entire Democratic campaign apparatus.
When a company's own lawyers warn it may have broken federal election law, and its response is to stop cooperating with Congress and call the investigation "partisan theater," the word for that is not defiance. It is evasion, and Congress has every right to treat it accordingly.
